Full-Time

Clinical Case Educator

Oncology/Specialty

Confirmed live in the last 24 hours

Deadline 7/18/25
McKesson

McKesson

Healthcare distribution and logistics services provider

Compensation Overview

$31 - $51.66/hr

+ Bonus + Long-term Incentive Opportunities

Mid, Senior

Morrisville, NC, USA + 1 more

More locations: Fort Worth, TX, USA

Hybrid

Nurses are required to report to the office twice a month for training and special meetings.

Category
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Requirements
  • Degree or equivalent and typically requires 4+ of relevant experience or a combination of education and experience.
  • Associates, Bachelor or higher degree in Nursing or accredited nursing diploma
  • Active RN license in NC/TX
  • 4+ years of nursing experience with at least 1 year of acute.
  • Experience in Oncology or other specialties.
  • Registered Nurse with current unrestricted compact state license or primary NC licensure. TX RN license is required for residents of TX.
  • Ability to obtain licensing in all states and United States territories serviced within 3 months of employment through Biologics supported programming (minimal application guidelines apply).
  • Computer skills, including e-mail, word processing, spreadsheet and web-based programs.
  • Effective orally and in writing communication, experience with motivational interviewing preferably.
  • Ability to read, analyze and interpret practice standards, professional journals, technical procedures and government standards and regulations.
Responsibilities
  • Counsel and educate new/existing patients on specialty drug therapies.
  • Adherence to contracted and accrediting regulations as indicated by drug specification.
  • Complete, thorough, and accurate documentation utilizing good documentation practice and compliance to industry standards and regulations.
  • Discuss potential/current side effects with patients to educate about treatment alternatives and facilitate ongoing therapy adherence.
  • Identify and report adverse events (AEs) and product complaints (PCs) to the manufacturer, FDA, and/or other governing authorities.
  • Specialty drug verification and education. Provider/patient conduit to support therapeutic longevity.
  • Adherence to patient management programs through call cadence schedules, medication management programing, drug counseling and provider collaboration.
  • Maintenance of patient demographic records, medical history, and records in accordance with federal HIPAA standards.
  • Collaboration with Pharmacy Support teams to ensure timely and accurate delivery of specialty drugs.

McKesson Corporation operates in the global healthcare sector, focusing on improving patient care through a wide range of products and services. The company works with healthcare providers, pharmacies, and manufacturers to ensure the efficient delivery of medicines and medical products. McKesson acts as a middleman, purchasing medical supplies from manufacturers and distributing them to various healthcare facilities, ensuring that essential items are available when needed. Their revenue comes from selling pharmaceuticals and medical products, as well as providing logistics and supply chain management services. Additionally, McKesson offers technology solutions to help healthcare providers streamline their operations. The company's goal is to facilitate the healthcare supply chain, making sure that critical medical supplies and services reach patients effectively.

Company Size

N/A

Company Stage

IPO

Headquarters

Irving, Texas

Founded

1833

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of PRISM Vision boosts earnings by up to $0.75 per share.
  • Expansion into home healthcare services increases demand for reliable distribution.
  • Increased focus on digital health solutions drives demand for integrated platforms.

What critics are saying

  • Increased competition in the OTC market impacts Foster & Thrive brand.
  • Supreme Court decision may lead to increased litigation risks for McKesson.
  • $2 billion notes offering increases financial leverage, posing potential financial risks.

What makes McKesson unique

  • McKesson's extensive network ensures timely delivery of medical supplies globally.
  • Their technology solutions enhance healthcare providers' operational efficiency.
  • Strategic partnerships strengthen McKesson's role in the global healthcare supply chain.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

401(k) Company Match

Company News

Healthcare Packaging
Jul 9th, 2025
McKesson's New Consumer-Focused OTC Brand Includes an Aluminum Packaging Line

To help consumers manage common health concerns independently, McKesson has launched its new readily available OTC line, Foster & Thrive.

Consumer Financial Services Law Monitor
Jun 20th, 2025
Supreme Court Rules Hobbs Act Does Not Bind District Courts to Agency Interpretations

The case stemmed from McKesson Corporation's allegedly unsolicited fax advertisements sent in violation of the Telephone Consumer Protection Act (TCPA).

Stroock & Stroock & Lavan LLP
Jun 2nd, 2025
McKesson Corporation Completes $2 Billion Notes Offering

Simpson Thacher represented McKesson Corporation in connection with a public offering of $2 billion aggregate principal amount of notes, consisting of $650 million aggregate principal amount of 4.650% Notes due 2030, $650 million aggregate principal amount of 4.950% Notes due 2032 and $700 million aggregate principal amount of 5.250% Notes due 2035. McKesson intends to use the net proceeds from the offering, together with cash on hand and/or commercial paper program borrowings, to fund its acquisition of a 70% controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC, an internal business and administrative services organization established by Florida Cancer Specialists & Research Institute, LLC.

Slater Sentinel
Mar 26th, 2025
Virtu Financial LLC Makes New $570,000 Investment in McKesson Co. (NYSE:MCK)

Virtu Financial LLC makes new $570,000 Investment in McKesson Co. (NYSE:MCK).

Bizjournals
Mar 18th, 2025
Fortune 50 company puts local facility in midst of closing up for sale

The move came after McKesson informed the state last September that it intended to lay off 13 employees at the facility.